ADHD drug prescriptions surge 38% in 2 years
Prescriptions for methylphenidate, an attention-deficit hyperactivity disorder (ADHD) treatment widely known as "study drug" among students in Korea, have surged nearly 38 percent over the past two years in the country and are especially high among people aged 19 and under, data showed Sunday. According to the Ministry of Food and Drug Safety and the Korea Institute of Drug Safety and Risk…
Attention-deficit hyperactivity disorder (ADHD) medication prescriptions in Korea have skyrocketed by nearly 38 percent over the past two years, according to recent data. The surge is particularly pronounced among individuals aged 19 and younger. In the first half of this year, 58.05 million methylphenidate tablets were prescribed, a 12.1 percent increase from the same period in 2023.
This represents a 37.8 percent rise compared to the first half of 2024, when 42.13 million tablets were dispensed. Notably, individuals in the 19-and-under age group accounted for approximately half of all methylphenidate prescriptions.
Written by urgent.news from The Korea Times's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
- ADHD drug prescriptions surge 38% in 2 years koreatimes.co.kr
